Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pharming Group N.V. - ADS, each representing 10 ordinary shares (NQ:PHAR)

12.12 +0.25 (+2.11%)
Delayed Quote Updated: 11:05 AM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pharming Group N.V. - ADS, each representing 10 ordinary shares

< Previous 1 2 3 4 5 Next >
News headline image
Pharming (PHAR) Q3 2026 Earnings Call Transcript ↗
Revenue grew 21% year-over-year as RUCONEST stabilized and Joenja expanded internationally. 
Via The Motley Fool
Topics Earnings
News headline image
Pharming Group Q3 Earnings Call Highlights ↗
Pharming Group (NASDAQ:PHAR) reported third-quarter revenue growth of 21% to $117.6 million, supported by higher sales of its RUCONEST hereditary angioedema treatment and Joenja therapy for activated... 
Via MarketBeat
Topics Earnings
News headline image
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
From Pharming Group N.V.
Via GlobeNewswire
Pharming Stock Draws Retail Buzz After FDA Seeks More Data For Pediatric Immune Drug — Why Investors Aren’t Panicking ↗
Via Stocktwits
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Pharming Group announces third quarter 2026 revenues above market expectations
From Pharming Group N.V.
Via GlobeNewswire
News headline image
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
From Pharming Group N.V.
Via GlobeNewswire
News headline image
Pharming announces CEO transition
From Pharming Group N.V.
Via GlobeNewswire
News headline image
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
From Pharming Group N.V.
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Pharming Group N.V. (PHAR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)
From Levi & Korsinsky
Via Business Wire
News headline image
Pharming (PHAR) Q2 2026 Earnings Call Transcript ↗
Joenja revenue surged 40% as RUCONEST stabilized amid competitive pressure. 
Via The Motley Fool
Topics Earnings
News headline image
Pharming (PHAR) Q2 2026 Earnings Call Transcript ↗
Joenja revenue surged 40% as RUCONEST stabilized amid competitive pressure. 
Via The Motley Fool
Topics Earnings
News headline image
Pharming Group Q2 Earnings Call Highlights ↗
Pharming Group (NASDAQ:PHAR) reported second-quarter revenue of $90.2 million, down 3% from a year earlier, as growth from its Joenja treatment partly offset lower sales of hereditary angioedema... 
Via MarketBeat
Topics Earnings
News headline image
Pharming Group Q1 Earnings Call Highlights ↗
Pharming Group (NASDAQ:PHAR) executives said first-quarter 2026 results reflected an expected decline in RUCONEST revenue tied largely to specialty pharmacy inventory movements and the company’s... 
Via MarketBeat
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
From Pomerantz LLP
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday. 
Via Benzinga
Topics Stocks
News headline image
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket ↗
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of... 
Via Benzinga
Topics Artificial Intelligence
News headline image
What Analysts Are Saying About Pharming Stock ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 13, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.